NEPH

Nephros Inc. Common Stock (NEPH)

Stock · NASDAQ · Health Care

$3.61as of 10/16/2026

Price chart

Open in TradingView

Active signals

Revenue-Price Divergence (1Y+)100.0%Support Confirmation66.6%
High Beta37.6%
200 SMA Touch13.2%
Support level
$3.49
Industry
Medical/Dental Instruments

NEPH Signal Track Record

How signals performed across all stocks →

What NEPH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike47-1.9%43%
Bollinger Band Breakout28+0.3%50%
Bollinger Band Breakdown18+6.3%56%
200-Day Moving Average TouchActive now4+5.2%50%
Any 20-session window (baseline)+0.5%51%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as we…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
36

Fundamentals

1-day range
$3.41$3.66
Market cap
$38.98M
P/E (trailing)
21.52
P/E (forward)
16.71
EPS (trailing)
$0.16
Dividend yield
—
Beta
1.74
Avg. volume
29.5K
Dividend pay date
July 10, 2019
52-week range
$2.66$6.42
Next earnings: November 5, 2026 · EPS estimate $0.03confirmed

How Nephros Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$18.79MNet Income$1.19M (6%)SG&A$9.00M (48%)Cost of Revenue$7.16M (38%)R&D$1.34M (7%)Other$80.0K (0%)Tax$12.0K (0%)NEPH

Source: 10-K filed Mar 12, 2026 · via SEC EDGAR / Finnhub

Gross Profit$11.63M(62%)
Operating Income$1.15M(6%)

Forecasts

3 analyst ratings

Buy 78%
Hold 22%
Sell 0%
1-year price forecast
High
$8
+121.6%
Median
$6
+66.2%
Low
$4.75
+31.6%

Nephros Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • NEPH
    Nephros Inc. Common Stock
    $3.65
    ▲ 3.99%
    Market cap $38.98MP/E 21.52
    $2.66$6.42
  • TELA
    TELA Bio Inc. Common Stock
    $0.975
    ▼ 3.47%
    Market cap $38.50MP/E —
    $0.5011$1.56
  • PAVM
    PAVmed Inc. Common Stock
    $2.41
    ▼ 0.62%
    Market cap $35.93MP/E —
    $2.27$28.44
  • NSPR
    InspireMD Inc. Common Stock
    $0.46
    ▼ 4.17%
    Market cap $33.87MP/E —
    $0.4604$2.54
  • ARAY
    Accuray Incorporated Common Stock
    $0.16
    ▼ 5.88%
    Market cap $33.63MP/E —
    $0.1615$1.86
  • SRTS
    Sensus Healthcare Inc. Common Stock
    $2.77
    ▲ 0.00%
    Market cap $49.06MP/E —
    $2.66$5.49
  • SKYA
    SkyAI Inc. Common Stock
    $2.65
    ▼ 3.28%
    Market cap $49.52MP/E —
    $0.91$2.77

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
50.1K
Disposed
3.38M

Institutional Ownership

March 31, 2026

Total shares held
5.33M
Total value held
$15.89M
Institutional holders
26
Top holders this quarter
  • Unknown3.60M
  • Unknown582.0K
  • Unknown198.6K
  • Unknown128.7K
  • Unknown121.2K
  • Unknown120.0K
  • Unknown110.9K
  • Unknown99.4K
  • Unknown72.9K
  • Unknown59.7K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.